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Background: Protein kinase C epsilon (PKCε) belongs to the novel PKC subfamily, which consists of diacylglycerol
dependent- and calcium independent-PKCs. Previous studies have shown that PKCε is important in different
contexts, such as wound healing or cancer. In this study, we contribute to expand the knowledge on PKCε by
reporting its expression pattern during murine midgestation using the LacZ reporter gene and immunostaining
procedures.
Results: Sites showing highest PKCε expression were heart at ealier stages, and ganglia in older embryos. Other
stained domains included somites, bone, stomach, kidney, and blood vessels.
Conclusions: The seemingly strong expression of PKCε in heart and ganglia shown in this study suggests a
important role of this isoform in the vascular and nervous systems during mouse development. However, functional
redundancy with other PKCs during midgestation within these domains and others reported here possibly exists
since PKCε deficient mice do not display obvious embryonic developmental defects.
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The mammalian protein kinase C family embraces ten
serine/threonine kinase isoforms divided into three
subfamilies: classical PKCs (cPKCs, α, βΙ, βΙΙ and γ),
novel PKCs (nPKCs, δ, ε, η and θ), and atypical PKCs
(aPKCs, ζ , ι/λ). Like all nPKCs, PKCε does not depend
on calcium but on diacylglycerol to become active,
since its C2 domain-like sequence lacks residues with
calcium-coordinating side chains [1]. Regarding PKCε
regulation, phosphorylation of the PKCε catalytic domain
is required so that PKCε can reach full enzymatic activity
[2], whereas phosphorylation of one of the serine residues
of its regulatory domain enables the interaction of PKCε
with 14-3-3 proteins [3]. In addition to the regulatory do-
mains of the PKC family, PKCε also contains an exclusive
motif that binds actin and allows for its phosphorylation
[4]. Therefore, actin, as well as other proteins, such as
histone1 [5] or TRAM [6], can interact and serve as PKCε
substrates. In addition, phosphorylation by PKCε of mole-
cules such as Akt [7] or PKD [8] make evident the signifi-
cant role of this nPKC isoform in the regulation of cell* Correspondence: s.c.huroz@biotek.uio.no
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reproduction in any medium, provided the orsignaling. PKCε also regulates ion channels, such as
GABAA receptors [9], or cytoskeleton proteins, as for
example vimentin [10] and actin as above mentioned
[4,11]. PKCε is also involved in different cellular events,
as for example cell migration [12] and cell division [13].
Although PKCε deficient mice are viable [14], they dis-
play several phenotypes, such as impaired cutaneous
wound closure [15], improved glucose-induced insulin
secretion and reduction of insulin clearance [16], and
glomerulosclerosis and tubulointerstitial fibrosis [17].
In addition, PKCε has been suggested as a promoter of
different types of cancer [18-20]. Hence, PKCε also
appears important in pathological scenarios. However,
the overall expression pattern of this isoform has not
been reported yet. In this study, we show the spatio-
temporal expression of PKCε in mouse during embryo-
genesis by using PKCε null embryos containing the
LacZ reporter gene under the control of the endogenous
PKCε promoter [14], and by staining wild type embryos
with antibodies to PKCε. Thus, these data contribute to
the general understanding of the expression of murine
PKCε in vivo, and to ellucidate exclusive or redundant
roles of PKCε.tral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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PKCε expression at E8.5 and E9.5
PKCε analysis through LacZ staining was performed from
E8.5 to E14.5. Given the absence of obvious developmental
phenotypes, homozygous embryos were chosen to report
LacZ stained domains due to their increased signal, mainly
at earlier stages, versus their heterozygous littermates. In
addition, antibody staining with corresponding negative
controls was performed at E9.5 and E13.5 as a control
for the specifity of the LacZ signal. Moreover, to confirm
the absence of endogenous β-galactosidase activity in our
stainings, wild type littermates underwent the same LacZ
staining protocol (Figure 1A-C). Background problems
using in situ hybridization prevented us from obtaining
reliable signal, and therefore data obtained with this tech-
nique were not included here. However, there is a recent
in situ hybridization study of the mouse transcriptome at
E14.5 that shows mRNA expression of PKCε at domains
that we also report here [21,22], which further strengthens
our data.
At E8.5, Lac Z activity was mainly detected at the
primitive heart, along with some weak signal in the yolk
sac (Figure 1D). LacZ signal was noticeably increased at
E9.5 in the developing heart (Figure 1E), and weak novel
staining was detected at somites and Rathke’s pouch
(Figure 1F and G respectively). Consistently, immunostain-
ing of WT whole embryos and sections of the embryonic
stage showed similar staining pattern, with heart, somites
and Rathke’s pouch as the domains showing immunoreac-
tivity (Figure 1H and I). PKCε deficient embryo sections
were used as a negative control (Figure 1J). A closer look at
the heart on immunostained sections allowed us to observe
PKCε expression mainly at the walls of the primitive
ventricle (ven), atrium (atr) and truncus arteriosus (tru)
(Figure 1K). Immunodetection of PKCε at this stage
could be detected at most cells in somites (Figure 1L)
and Rathke’s pouch (Figure 1M). The absence of signal
in PKCε deficient sections and the overlapping pattern
obtained through both staining methods confirmed the
specifity of the signal at the reported domains through
both approaches.
PKCε expression from E10.5 to E12.5
In E10.5 whole mount embryos, the nervous system
became noticeable through β-galactosidase staining. Thus,
neural tube in caudal region of tail, dorsal root ganglia,
trigeminal (V) neural crest, facio-acoustic (VII-VIII) neural
crest complex all showed Lac Z signal, along with
cephalic mesenchyme tissue and roof of the hindbrain
(Figure 2A-C). X-Gal staining was still strong in the
heart at this stage and onwards.
At E11.5, dorsal root ganglia and trigeminal (V) ganglion
was strongly stained. Moreover, fascio-acustic (VII-VIII)
ganglion complex, and interior ganglion of vagus (X) nerveall showed prominent LacZ reporter gene expression
(Figure 2D). The strong LacZ signal observed in heart
and ganglia at this stage and onwards suggests an
important role of PKCε within the vascular and nervous
systems. However, the lack of obvious developmental
defects suggests the existence of functional redundancy
with other PKC isoforms. PKCδ might be a candidate in
this regard given its similar expression pattern [23].
At E12.5, whole mount lacZ staining still showed
clear signal in the neural and cardiovascular systems
(Figure 2E-H), but in addition signal at the caudal part of
medula oblongata (Figure 2F) and kidney (Figure 2G)
could be observed. In addition, although LacZ signal in
blood vessels was first weakly detected from E9.5, it was
from E12.5 when PKCε expression in this domain was
very obvious (Figure 2H). However, PKCε in blood vessels
could not be detected via immunostaining even at later
stages, when the LacZ activity in endothelium was even
clearer. Since PKCε appears expressed in vitro in mouse
embryonic endothelial cells (Figure 2I and Additonal file
1: Figure S1) as well as in endothelial cells from other spe-
cies [24-26], we speculate that endothelial PKCε expres-
sion in vivo is too low to be detected in mouse by the
antibody and/or protocol we used in our immunohisto-
chemistry. Hence, detection of PKCε expression in endo-
thelium via LacZ staining was perhaps possible because
the Neo cassette that was used to generate PKCε defi-
cient mice [15] upregulated PKCε expression in endothe-
lium, as previously shown for other genes and tissues [27].
PKCε expression at E13.5 and E14.5
In addition to blood vessels, ganglia, and other LacZ-
stained domains described at previous stages, reporter
activity at E13.5 was detected in the pinna of the ear,
chroroid plexus and ventral part of medulla oblongata
(Figure 3A). A closer look on E13.5 LacZ-stained sections
showed that only some and not all cells in the trigemi-
nal and dorsal root ganglia were responsible for the
strong X-Gal staining observed on these domains
(Figure 3B-D). This might be due to penetration
related issues of X-Gal, which would have prevented
the staining of the whole domain. β-galactosidase
activity was also observed in urogenital sinus, dorsal
part of the jaw, heart, mucosal lining of the stomach
and limbs (Figure 3E-H). The signal detected at the heart
was located at the trabeculated part of the wall of the
ventricles (Figure 3F). Immunostaining of sagittal and
cross sections at E13.5 could confirm PKCε expression
at domains previously reported via LacZ staining as well
as other new domains that were not detected through
LacZ activity. However, such domains were not stained in
PKCε deficient mouse sections (Figure 3I) and therefore
appear specific. Ganglia was the most prominently immu-
nostained domain, as observed via LacZ. Thus, antibodies
Figure 1 PKCε expression at E8.5 and E9.5. A-C, lack of Lac Z signal due to endogenous β-galactosidase was confirmed on wild type embryos
(controls). D, at E8.5, X-Gal staining is detected in the yolk sac and primitive heart (ys and ph, respectively). E-G, at E9.5, developing heart (hea),
somites (som) and Rathke’s pouch (Rp) showed LacZ signal. H-M, Antibody staining of 5 μm E.9.5 embryo sections confirmed the expression of
PKCε in somites, Rathke’s pouch and heart. In the latter domain, immunoreactivity was detected at the walls of the primitive ventricle (ven),
atrium (atr) and truncus arteriosus (tru). E9.5 PKCε deficient embryo sections were used as a negative control for the antibody (J).
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(Figure 3J and L), hypothalamus, trigeminus and cerebral
cortex (Figure 3K), neural tube (Figure 3L), urogenital sinus
(Figure 3M), kidney and mucosal lining of the stomach
(Figure 3N), heart (Figure 3O) and limbs (Figure 3P).
As expected, and consistent with previous mRNA
analysis of embryos at E14.5 [22], PKCε was still detected
at domains such as root ganglia or brain (Figure 4A).However, at this stage X-Gal staining was also observed on
yet unreported domains at the mRNA level, such as blood
vessels (already detected in this study at earlier stages),
snout –except for whiskers (Figure 4B), umbilical chord
(Figure 4C), and precartilage primordium of bone, mainly
at forelimbs and hindlimbs. Thus, radius, precartilage
primordium of phalangeal, metacarpal and carpal bone
were showing remarkable LacZ activity (Figure 4D).
Figure 2 PKCε expression in whole mount embryos from E10.5 to E12.5. A -C, At E10.5, trigeminal neural crest (tnc), facio-acoustic neural
crest complex (fac), neural tube in caudal region of the tail (nt), cephalic mesenchyme (cm), dorsal root ganglia (drg), and roof of the hindbrain
(rh) show reporter activity. D, At stage E11.5, staining of the trigeminal (V) ganglion (trg), facio-acoustic (VII-VIII) ganglion complex (fac), dorsal root
ganglia (drg), as well as interior ganglion of vagus (X) nerve (ivn) became all prominently LacZ stained. E-H, At E12.5, novel LacZ activity in the
caudal part of the medula oblongata (cmo) and developing kidney (dk) can be detected. Embryos at this stage also show clear LacZ signal in
blood vessels (fig. H), which was weakly detectable from E9.5. I, Western blotting showing expression of PKCε in wild type mouse embryonic
endothelial cells (MEECs). PKCε deficient MEEC were used as negative control and VEGFR2 was used as endothelial marker.
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Our expression pattern for PKCε during mouse
midgestation suggests that at least several domains,
such as ganglia, vascular system, cartilage primordium
or stomach, express this novel PKC isoform. However,
heart and nervous system appear as the main sites of
expression for PKCε. More specifically, dorsal root
ganglia and trigeminal (V) ganglia are the domains
where PKCε seems to be most prominently expressed.
Thus, as already indicated by mouse ex vivo studies
[28] and in vivo work performed in rats [29], these data
suggest that PKCε likely has an important in vivo role
within the nervous system in mice. The fact that there
is no reported phenotype or functional deficiency in the
nervous system in mice suggests the existence of func-
tional redundancy among members of the PKC family.
Indeed, data regarding transcription of PKC δ [30] and ε
[21] within the same domains of the nervous system
already exist as part of a study that uses an in situ
hybridization approach to show the expression pattern of
a high number of transcripts in the mouse embryo [22]. In
addition, our recent description of the expression pattern
for PKC δ at the protein level during mouse midgestation
[23] together with the present study also show the co-
existence of these two nPKC isorforms within the vas-
cular and nervous systems. Thus, the expressionpattern of PKCε may contribute to address such redun-
dancy by pointing us towards domain(s) causing poten-
tial lethality in mice lacking several PKC isoforms.
Methods
Animals and embryo collection
Mice deficient for PKCε have been previously described
[14]. All the animal work was approved by the Folkehelse
Institute in Oslo (Norway), and performed according to
its institutional guidelines and rules and regulations of
the Federation of European Laboratory Animal Science
Association’s (FELASA). Pregnancy stages were assigned
upon observation of vaginal plug at approximately midday,
which was considered as E0.5.
Cell culture
Wild type and PKCε deficient mouse embryonic endothelial
cells (MEECs) were generated by digesting E11.5 embryos
in a collagenase/dispase cokctail (Roche) mixed with
DMEM+pyruvate (Gibco) for 20 min at 37°C. Embryos
were subsequently washed in PBS and incubated overnight
in DMEM supplemented with pyruvate, 10 μg/ml endothe-
lial cell growh supplement (Sigma) and 10% fetal calf serum
(complete medium). The next day, medium containing
debris and dead cells was removed, and supernatant
obtained from cultured cells producing polyoma virus
Figure 3 PKCε expression is highest within the nervous system at E13.5. A, at embryonic stage E13.5, whole mount staining allowed for the
detection of LacZ signal in choroid plexus (cho), ventral part of the medulla oblongata (vmo) and pinna of the ear (pin). B-H, 15 μm sagittal
sections at this stage showed incomplete penetration of X-Gal at previously reported domains such as dorsal root ganglia (drg) and trigeminal (V)
ganglion (trg). Lac Z signal at this stage was also detected in neural tube (nt), urogenital sinus (uro), caudal part of lower jaw (jaw), heart (hea),
mucosal lining of the stomach (sto), and limbs (lim). I, Immunohistochemistry at E13.5 included staining of PKCε deficient sections as negative
control. J, sagittal sections confirmed ganglia as the domain with highest expression of PKCε at this stage. K-P, Immunostaining of cross sections
(K-N) and sagittal sections (O and P) confirmed PKCε detected via LacZ staining in trigeminal ganglion (trg), choroid plexus (cho), neural tube
(nt), urogenital sinus (uro), mucosal lining of the stomach (sto), kidney (kid), heart, caudal part of lower jaw (jaw) and limbs (lim). In addition, it
also allowed for detection of PKCε in hypothalamus (K, hyp).
Carracedo et al. BMC Developmental Biology 2013, 13:16 Page 5 of 8
http://www.biomedcentral.com/1471-213X/13/16
Figure 4 PKCε expression at E14.5. A and its inset magnified in B show LacZ signal in the snout area (sno) except for whiskers (whi). C, β-Gal
activity was detected in umbilical vein (umb). D, precartilage of primordium of radius (rad) phalangeal (pha), metacarpal (met) and carpal (car)
bones (fig. V) all became clearly LacZ stained.
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was added together with 8 μg/ml polybrene (Sigma) for
two hours in order to selectively immortalize endothelial
cells [31]. Upon removing supernatant, complete medium
was added and cells were left in culture for several weeks.
As growing endothelial island appeared, removal of non-
endothelial cells was manually performed with a pippet to
allow endothelial islands to expand and reach confluence.
To confirm the endothelial phenotype and the purity of
our cells, VEGFR2 (Cell Signalling Technologies) and
VE-Cadherin antibodies (AH diagnostics) were used to
detect the corresponding endothelial markers via western
blot (Figure 1I) and immunofluorescence microscopy
(Additional file 1: Figure S1), respectively.
Western blotting
Cells were washed in PBS, trypsinized, and the resulting
pellets further lysed in SDS-sample buffer, sonicated,
boiled for 3 min, and subjected to a SDS-PAGE on 8%
gels. Proteins were then transferred onto nitrocellulose
membranes (GE Healthcare). Membranes were blocked
for 1 h at room temperature with 5% non-fat dry milk
(Marvel) in PBS containing 0.05% Tween 20 (PBS-T),
incubated with either primary antibody to VEGFR2
(Cell Signaling, 1:1000), PKCε (Santa Cruz biotech-
nologies, 1:1000) or GAPDH (Cell Signaling 1:5000)
overnight at +4°C. Upon washing in PBS-T three times,
membranes were further incubated with goat anti-
rabbit horseradish peroxidase-conjugated secondary
IgGs (Jackson Immunoresearch, 1:5000) for 3h at room
temperature. Membranes were was three times and
developed using the SuperSignal West Pico kit
(Thermo-Scientific Pierce) and photographed using
the ChemiDoc XRS device and the Quantity One 1-D
analysis software (Bio-Rad).
LacZ staining
Steps corresponding to fixation (4% paraformaldedyde
in PBS) and washing/permeabilization (Na2HPO4 85 mM,NaH2PO4 16 mM, MgCl2 2 mM, 0.01% Na-desoxycholate,
0.02% NP-40) were performed for either 5 min (embryos
up to 9.5 dpc) or 15 min (embryos from 10.5 dpc) at room
temperature. Upon isolation, embryos were fixed, washed
three times, and incubated with gentle shaking and
protected from light overnight at 37°C in staining solution
(for 10 ml, 9.7 ml of washing solution, 200 μl of K3
[Fe(CN)6] 0.5 M, 200 μl of K4[Fe(CN)6] 0.5 M, and 175 μl
of 50 mg/ml X-Gal (Sigma-Aldrich) in DMSO were used).
Next day, embryos were washed three times at room
temperature and postfixed in 4% formalin in washing
solution overnight at +4°C. PKCε deficient embryos
(unless otherwise stated) were then passed into increasing
concentrations of glycerol (25%, 50% and 80%) and
photographed by using a Zeiss stereoscope equipped with
camera and Axiovision software. LacZ stained embryos to
be sectioned were instead postfixed in bouin’s solution
(Sigma) the next day after β-gal staining was obtained,
washed 3 times in PBS, passed into increasing concentra-
tions of ethanol (30%, 50%, 70% and 100%, 2 washes per
concentration), placed into a mix 1:1 of Ethanol-xylene,
washed 2 times in xylene, and finally embedded in paraffin.
In order to better observed LacZ domains, sections were
obtained at a thickness of 15 μm and left overnight at room
temperature. They were next subjected to dewaxing as
follows: 2 washes in xylol for 10 min, 2 washes in absolute
ethanol for 5 min, 1 wash in 70% ethanol for 2 min, and at
least 5 min in distilled water. Sections were then mounted
on mowiol (Polysciences) and photographed.
Immunostaining
Upon fixation of embryos in 4% PFA overnight, embryos
were washed 3 times in PBS, passed into increasing con-
centrations of ethanol (30%, 50%, 70% and 100%, 2 washes
per concentration), placed into a mix 1:1 of Ethanol-xylene,
washed 2 times in xylene, and finally embedded in paraffin.
Five μm paraffin embedded sections of 9.5 and 13.5 dpc
embryos were subjected to dewaxing as follows: 2 washes
in xylol for 10 min, 2 washes in absolute ethanol for 5 min,
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distilled water. Sections were subsequently boiled for
two minutes in citric acid pH 6.0 for antigen retrieval,
washed three times in PBS, bleached for 20 min with a
mix of 30% peroxide, 1M HCl, and methanol with the
ratio 1:1:100, respectively, rinsed in PBS, and incubated
at 4°C overnight in rabbit polyclonal anti mouse PKCε
(Santa Cruz Biotechnology) in a 1:200 dilution in PBS
containing 5% fetal calf serum (FCS). Next day, sections
were washed in PBS and incubated 4°C overnight in goat
antirabbit IgGs conjugated to horse radish peroxidase
(HRP, Jackson Immunoresearch) in a 1:200 dilution in PBS
containing 5% FCS. Detection of PKCε was then analyzed
using the DBA method according to the manufacturer’s
instructions (Biogenex), rinsed in PBS and mounted in
mowiol (Polysciences). For immunofluorescent detection
of VE-Cadherin in MEECs (Additional file 1: Figure S1),
cells were seeded in a 12 well-plate for two days, fixed in
4% PFA for 10 min at room temperature, rinsed three
times in PBS for 5 min, permeabilized for 15 min with 10%
goat serum in PBS 0.1% Triton X-100, blocked in PBS 10%
sheep serum for 45 min, incubated in 1:200 rat anti mouse
VE-Cadherin (AH Diagnostics) in PBS overnight at 4°C,
rinsed three times in PBS, and incubated in 1:400 goat
anti-rat cy3 (Jackson Immunoresearch) in PBS for three
hours. Upon rinsing, immunofluorescence detection was
performed using a Nikon Eclipse Ti microscope.
Additional file
Additional file 1: Figure S1. Purity of MEEC lines. VE-Cadherin was
detected via immunofluorescence microscopy to confirm the purity of
WT and PKCε deficient MEECs. Nearly all cells appeared positively stained
in both genotypes. WT mouse embryonic fibroblasts (MEFs) were used as
a negative control.
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